-The Hindu Differences over intellectual property rights (IPRs) have emerged as a strong undercurrent in India's economic relations with the U.S. The attempt by the influential pharmaceutical lobby to stymie India's efforts to ensure the supply of medicines at affordable rates without violating existing treaty commitments, requires a principled response from New Delhi. At the core of the issue is what Columbia University Professor Arvind Panagariya calls "the hijacking of...
More »SEARCH RESULT
Total Matching Records found : 259
To plough a lonely furrow-Devinder Sharma
-DNA Elections 2014 are around the corner. And when elections draw nearer, the Government suddenly wakes up and thinks of its duties towards the people. This year is no exception. Whether it is the one-rank-one-pension for the retired defence personnel or the legal monthly entitlement of 5kg of wheat/rice/millet for poor households under the national Food Security Act or the announcement of a 7th Pay Commission along with a DA instalment...
More »UN Rapporteur calls for food democracy and agro-ecology in final report
-AgriculturesNetwork.org The United Nations Special Rapporteur on the right to food, Olivier De Schutter, today calls for radical transformation of the world's food systems. The emphasis in agricultural policy should shift from productivity to "well-being, resilience and sustainability", he says. This morning De Schutter presented his final report to the UN Human Rights Council after a six-year term as Special Rapporteur. In February, he also presented some of his findings at...
More »India must call the US' bluff on patents-Arvind Panagariya
-The Business Standard The recent US-India friction over trade is being driven by Big Pharma Apart from the deterioration of the business environment generally, which impacts both domestic and foreign investors, retrospective taxation has figured most prominently in the media as the principal cause of growing scepticism among foreign investors. Entirely missing from the discourse has been an equally potent factor with wholly foreign origins: the hijacking of the economic policy...
More »Outside the patent monopolies -Ritu Kamal
-The Indian Express India's role in pharmaceutical patent wars has broadened access to healthcare. Recently, there were rumours that the United States Trade Representative (USTR) was getting ready to announce "trade enforcement actions" or sanctions against India over its intellectual property rights regime. The Obama administration has been under pressure from the US Chamber of Commerce and lobby groups, like the Pharmaceutical Research and Manufacturers of America, to take a tough stance...
More »
